This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof CreamCDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis
Dr Reddys Acquires Progynova, Cyclo-Progynova Brands from Mercury PharmaDr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreBoston Scientific to acquire Nalu Medical for USD 533 million
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for...
Viatris buys Aculys Pharma to expand neurology portfolio in JapanViatris buys Aculys Pharma to expand neurology portfolio in Japan
Novartis AG to Exit India Arm in Rs 1,446 Cr Deal, ChrysCapital-Led Consortium Buys 70.68% StakeNovartis Scemblix receives positive CHMP opinion for newly diagnosed CML in adults
Strides, Incepta partner to expand women health access with WHO prequalified contraceptiveStrides, Incepta partner to expand women health access with WHO prequalified contraceptive
medicinesIPC Launches QR Code-Enabled Online ADR Reporting Platform to Boost Patient Safety
Former Pharma Executive Duped of Rs 87 Lakh in Online Stock Trading ScamPharmacist Falls Prey To Rs 1.75 Crore Land Investment Fraud in Gujarat
NPPA Expands I.V. Fluid Price List, Adds 5 Manufacturers and New PacksPharma Firm Gets HC Relief in Rs 64 Lakh NPPA Overpricing Row Over DOLOCIDE-MR
GSK Licenses Linerixibat to Alfasigma in Deal Worth Up to USD 690 MillionGSK Shingrix gets nod in China for adults aged 18 years and over with shingles
CDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Labs Nelarabine InjectionMSN Labs Gets SEC Nod for Roflumilast as Starting Dose in COPD Therapy
X